Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (1-10 of 365) with videos related to

Pageof 37
Sort By:
Internal Medicine Journal|December 5, 2022
Author replyChristopher C Rowe
International Psychogeriatrics|July 7, 2011
Amyloid imagingVictor L Villemagne, Christopher C Rowe
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 16, 2011
Brain amyloid imagingChristopher C Rowe, Victor L Villemagne
PET Clinics|May 10, 2016
Amyloid PET Ligands for DementiaVictor L Villemagne, Christopher C Rowe
Journal of Nuclear Medicine Technology|February 12, 2013
Brain amyloid imagingChristopher C Rowe, Victor L Villemagne
Journal of Alzheimer'S Disease : JAD|June 20, 2012
Long night's journey into the day: amyloid-β imaging in Alzheimer's diseaseVictor L Villemagne, Christopher C Rowe
The Medical Clinics of North America|May 7, 2013
Amyloid imaging with PET in early Alzheimer disease diagnosisChristopher C Rowe, Victor L Villemagne
Journal of Alzheimer'S Disease : JAD|June 26, 2014
Management impact of FDG-PET in dementia: results from a tertiary center memory clinicAlby Elias, Michael Woodward, Christopher C Rowe
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 5, 2016
Untangling tau imagingVictor L Villemagne, Nobuyuki Okamura, Christopher C Rowe
Journal of Alzheimer'S Disease Reports|May 15, 2024
Clinical Evidence for GLP-1 Receptor Agonists in Alzheimer's Disease: A Systematic ReviewYulin Liang, Vincent Doré, Christopher C Rowe, et al.
Pageof 37

Showing results (1-10 of 365) with videos related to

Sort By:
Pageof 37
Internal Medicine Journal|December 5, 2022
Author replyChristopher C Rowe
International Psychogeriatrics|July 7, 2011
Amyloid imagingVictor L Villemagne, Christopher C Rowe
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 16, 2011
Brain amyloid imagingChristopher C Rowe, Victor L Villemagne
PET Clinics|May 10, 2016
Amyloid PET Ligands for DementiaVictor L Villemagne, Christopher C Rowe
Journal of Nuclear Medicine Technology|February 12, 2013
Brain amyloid imagingChristopher C Rowe, Victor L Villemagne
Journal of Alzheimer'S Disease : JAD|June 20, 2012
Long night's journey into the day: amyloid-β imaging in Alzheimer's diseaseVictor L Villemagne, Christopher C Rowe
The Medical Clinics of North America|May 7, 2013
Amyloid imaging with PET in early Alzheimer disease diagnosisChristopher C Rowe, Victor L Villemagne
Journal of Alzheimer'S Disease : JAD|June 26, 2014
Management impact of FDG-PET in dementia: results from a tertiary center memory clinicAlby Elias, Michael Woodward, Christopher C Rowe
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 5, 2016
Untangling tau imagingVictor L Villemagne, Nobuyuki Okamura, Christopher C Rowe
Journal of Alzheimer'S Disease Reports|May 15, 2024
Clinical Evidence for GLP-1 Receptor Agonists in Alzheimer's Disease: A Systematic ReviewYulin Liang, Vincent Doré, Christopher C Rowe, et al.
Pageof 37